Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Colorectal Neoplasms
  • Liver Neoplasms, Experimental
  • Receptors, Urokinase Plasminogen Activator

abstract

  • uPAR MoAb therapy impaired CRC tumor growth in the liver in both small-volume and large-volume disease models.

publication date

  • August 18, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4608018

Digital Object Identifier (DOI)

  • 10.1002/cncr.24371

PubMed ID

  • 19484792

Additional Document Info

start page

  • 3360

end page

  • 8

volume

  • 115

number

  • 14